Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology
about
Protein phosphatase 2A dysfunction in Alzheimer's diseaseMechanism of inhibition of PP2A activity and abnormal hyperphosphorylation of tau by I2(PP2A)/SETProtein phosphatases and Alzheimer's diseaseReduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's diseaseThe Beta-amyloid protein of Alzheimer's disease: communication breakdown by modifying the neuronal cytoskeletonSignaling mechanisms and disrupted cytoskeleton in the diphenyl ditelluride neurotoxicityCircumventing embryonic lethality with Lcmt1 deficiency: generation of hypomorphic Lcmt1 mice with reduced protein phosphatase 2A methyltransferase expression and defects in insulin signalingmTOR-dependent signalling in Alzheimer's diseaseMammalian target of rapamycin (mTor) mediates tau protein dyshomeostasis: implication for Alzheimer diseaseUncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.Cytoplasmic SET induces tau hyperphosphorylation through a decrease of methylated phosphatase 2A.Basis for MAP4 dephosphorylation-related microtubule network densification in pressure overload cardiac hypertrophy.Unveiling clusters of RNA transcript pairs associated with markers of Alzheimer's disease progression.Therapeutic Re-Activation of Protein Phosphatase 2A in Acute Myeloid LeukemiaSphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A.The Role of Insulin and Insulin-Like Growth Factor-1/FoxO-Mediated Transcription for the Pathogenesis of Obesity-Associated Dementia.Activation of protein phosphatase 2B and hyperphosphorylation of Tau in Alzheimer's disease.Sustained postexercise increases in AS160 Thr642 and Ser588 phosphorylation in skeletal muscle without sustained increases in kinase phosphorylationAdvances in the pathogenesis of Alzheimer's disease: focusing on tau-mediated neurodegeneration.Chronic hyperglycemia induced via the heterozygous knockout of Pdx1 worsens neuropathological lesion in an Alzheimer mouse modelEarly glycogen synthase kinase-3β and protein phosphatase 2A independent tau dephosphorylation during global brain ischaemia and reperfusion following cardiac arrest and the role of the adenosine monophosphate kinase pathwayTau pathology involves protein phosphatase 2A in parkinsonism-dementia of Guam.The role of tau in Alzheimer's disease and related disorders.Screening of treatment targets for Alzheimer's disease from the molecular mechanisms of impairment by β-amyloid aggregation and tau hyperphosphorylation.Possible implications of insulin resistance and glucose metabolism in Alzheimer's disease pathogenesis.Microtubule-associated protein tau as a therapeutic target in Alzheimer's disease.Environmental factors in the development and progression of late-onset Alzheimer's disease.The role of intracellular zinc release in aging, oxidative stress, and Alzheimer's disease.All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase.Morroniside-Induced PP2A Activation Antagonizes Tau Hyperphosphorylation in a Cellular Model of Neurodegeneration.Zinc binds to and directly inhibits protein phosphatase 2A in vitroProtein Phosphatase 2A: a Double-Faced Phosphatase of Cellular System and Its Role in Neurodegenerative Disorders.Microcystin-LR induces protein phosphatase 2A alteration in a human liver cell line.Glycogen synthase kinase-3β regulates leucine-309 demethylation of protein phosphatase-2A via PPMT1 and PME-1.Tau kinases and phosphatases.Diphenyl ditelluride induces hypophosphorylation of intermediate filaments through modulation of DARPP-32-dependent pathways in cerebral cortex of young rats.Lack of JWA Enhances Neurogenesis and Long-Term Potentiation in Hippocampal Dentate Gyrus Leading to Spatial Cognitive Potentiation.Glycogen synthase kinase-3β regulates Tyr307 phosphorylation of protein phosphatase-2A via protein tyrosine phosphatase 1B but not Src.Untangling Tau and Iron: Exploring the Interaction Between Iron and Tau in Neurodegeneration
P2860
Q21090465-4FC90ED6-C0D7-430E-A535-6CAACCE88EFDQ24318458-B924E43F-25A6-4DC7-895E-A0AF6C7F1F6AQ24632495-D5BB9EF0-01BB-45A6-8FF5-DB64D6DE9D52Q24656640-F99B38A4-6127-4456-B503-36A8E250FD7BQ26864818-6DADDEC0-11CE-490A-8384-AFDB75BE01EBQ27026946-D27F719C-97E0-4D62-A159-9A1E3EE410FFQ27315944-3E88460C-0E3B-4615-AA78-B3ECEDD16750Q28308319-E129FF56-00EF-46B1-9DD3-52E9171BE1CBQ30412891-64846F32-D16A-464A-B059-E5C8100AA4ACQ30494084-54BB75A3-1F5C-4419-A78B-10D9985331F5Q33861397-CBA2294B-3F20-43F1-BAA0-7BFA015FEC21Q34352102-36A83E5E-6310-4118-9754-4DBC63CAB866Q34429308-403C537F-338C-4E11-9FFF-B325EA1293F1Q35037262-BF7F2E2C-C1E9-47A8-B3E1-EDADA1DBBDC9Q35037415-B4DBEAE9-82F6-45FC-A373-824276411570Q35986310-C5D12A58-4BC4-44BF-BEF1-C1DDFAE5D22CQ36039037-5457C723-2759-4FE4-8F2B-2281EA21F8F4Q36530922-705BD6F1-ED5E-4DD2-BF99-E849865F6F8AQ36688393-373F045C-AB20-4279-8957-B8DFB8C39DB1Q37089126-A27A4E8B-6930-4175-8C93-E8A5D0A2FE0DQ37384934-73E1BD06-797A-47D9-8694-8DDD8C7941AEQ37519695-5FC51299-369E-4DDE-81ED-125F15418B5AQ37765632-BA5B4526-05CE-499F-B3CE-D2BAECA526C4Q37832656-A2170F8B-5F86-49E3-8427-46931EBB561BQ37857377-846A4DCA-D26B-4318-AF35-F6974069D05EQ38175453-E00CC778-200E-4E41-9A51-F1C2F82FF6B2Q38199061-C4D8F7AE-99F5-47C5-BA0F-44927FB37E31Q38214602-CC7CA750-FA4E-4366-937C-09D8C4310D1BQ38617799-BC5F29BB-FAC2-4A9F-B71D-2706F9CEBA5BQ38797416-73DF176D-4EBF-4CA5-9B02-DE6B620F3889Q38889604-CD3DD5C6-5ADD-47F8-80F6-72363D47CA47Q39146231-18009D5A-CD64-4533-8318-832AB57AB1DDQ39189431-D4C691CA-99F6-4CFF-B00D-2AF2DC38C012Q39325433-F93E6EDB-A96C-4501-8B68-A7062A6B18C6Q42243989-AFC7A155-9185-4716-A721-54DEF38A0F43Q42727378-A623DB8E-1546-4BBC-B08D-3B1242593DAEQ48444515-7904A27E-5BBD-41D7-A69E-E46061A485CAQ54591455-7D586E31-8370-4033-B62C-C4AB84FCA077Q58769184-AFB19FC4-1BD9-4E60-A701-787DD56D882E
P2860
Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology
@en
Phosphorylated PP2A
@nl
type
label
Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology
@en
Phosphorylated PP2A
@nl
prefLabel
Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology
@en
Phosphorylated PP2A
@nl
P2093
P2860
P921
P1476
Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology
@en
P2093
C Bjorkdahl
J-A Gustafsson
P2860
P304
P356
10.1111/J.1582-4934.2008.00249.X
P577
2008-01-19T00:00:00Z